Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial

NCT07746154 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07746154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha Down EEG Neurofeedback for Alcohol Use Disorder: Feasibility Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
February 1, 2028
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)